| appearance as argument number 1 |
|
| (diseaseMedicine Upadacitinib RheumatoidArthritis Ingesting) | Medicine.kif 5547-5547 | diseaseMedicine Upadacitinib, RheumatoidArthritis and ing�rer |
| (documentation Upadacitinib EnglishLanguage "Upadacitinib, sold under the brand name Rinvoq, is a Janus kinase (JAK) inhibitor medication for the treatment of moderately to severely active RheumatoidArthritis in adults where methotrexate (a drug used to treat active arthritis) did not work well or could not be tolerated. It was developed by the biotech company AbbVie. Common side effects include upper respiratory tract infections (common cold, sinus infections), Nausea, Cough, and Fever.[from Wikipedia]") | Medicine.kif 5539-5546 | |
| (sideEffect Upadacitinib Fever) | Medicine.kif 5549-5549 | sideEffect Upadacitinib and Fever |
| (sideEffect Upadacitinib Nausea) | Medicine.kif 5548-5548 | sideEffect Upadacitinib and Nausea |
| (subclass Upadacitinib Medicine) | Medicine.kif 5537-5537 | Upadacitinib est une sous-classe de Medicine |
| appearance as argument number 2 |
|
|
| (subclass Rinvoq Upadacitinib) | Medicine.kif 5552-5552 | Rinvoq est une sous-classe de Upadacitinib |
| (termFormat EnglishLanguage Upadacitinib "upadacitinib") | Medicine.kif 5550-5550 |
|
Show full definition with tree view
Show simplified definition (without tree view)
Show simplified definition (with tree view)
|
|
Sigma web home Suggested Upper Merged Ontology (SUMO) web home
Sigma version 3.0 is open source software produced by Articulate Software and its partners